REC-1245

· Recursion Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REC-1245, covering 2025-12-05 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer [Phase 1, Phase 2]